Your browser is no longer supported. Please, upgrade your browser.
BLUE [NASD]
bluebird bio, Inc.
Index- P/E- EPS (ttm)-10.98 Insider Own0.40% Shs Outstand66.25M Perf Week4.10%
Market Cap3.34B Forward P/E- EPS next Y-11.09 Insider Trans-9.37% Shs Float66.04M Perf Month13.91%
Income-642.20M PEG- EPS next Q-2.90 Inst Own97.70% Short Float10.53% Perf Quarter-8.59%
Sales250.00M P/S13.37 EPS this Y-34.00% Inst Trans0.16% Short Ratio6.21 Perf Half Y-23.72%
Book/sh22.99 P/B2.20 EPS next Y-12.10% ROA-35.10% Target Price80.21 Perf Year-48.16%
Cash/sh18.60 P/C2.72 EPS next 5Y- ROE-45.80% 52W Range38.95 - 99.36 Perf YTD16.78%
Dividend- P/FCF- EPS past 5Y-50.80% ROI-63.40% 52W High-49.14% Beta1.74
Dividend %- Quick Ratio6.60 Sales past 5Y11.90% Gross Margin98.00% 52W Low29.73% ATR2.45
Employees1171 Current Ratio6.60 Sales Q/Q116.90% Oper. Margin- RSI (14)60.29 Volatility6.39% 4.86%
OptionableYes Debt/Eq0.00 EPS Q/Q21.10% Profit Margin- Rel Volume0.97 Prev Close51.85
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume1.12M Price50.53
Recom2.00 SMA208.67% SMA509.79% SMA200-8.85% Volume1,089,171 Change-2.55%
Dec-09-20Downgrade Maxim Group Buy → Hold
Nov-11-20Initiated Berenberg Buy
Nov-05-20Downgrade Stifel Buy → Hold $77 → $51
Nov-05-20Downgrade BMO Capital Markets Outperform → Market Perform $108 → $56
Nov-05-20Downgrade Barclays Overweight → Equal Weight
Nov-02-20Upgrade William Blair Mkt Perform → Outperform
Oct-20-20Initiated Mizuho Buy $123
May-13-20Initiated RBC Capital Mkts Outperform $100
Mar-27-20Upgrade Stifel Hold → Buy $70
Feb-19-20Downgrade Raymond James Strong Buy → Mkt Perform
Feb-19-20Downgrade Raymond James Outperform → Mkt Perform
Feb-03-20Upgrade Evercore ISI In-line → Outperform $86 → $100
Feb-03-20Resumed BofA/Merrill Buy $120
Dec-13-19Upgrade Oppenheimer Perform → Outperform $135
Nov-26-19Upgrade SVB Leerink Mkt Perform → Outperform $119
Nov-19-19Downgrade Evercore ISI Outperform → In-line $86
Nov-04-19Upgrade Wedbush Neutral → Outperform $131 → $124
Oct-01-19Initiated Stifel Hold $109
Aug-12-19Downgrade William Blair Outperform → Mkt Perform
Jun-18-19Upgrade Maxim Group Hold → Buy $160
Jan-14-21 12:34PM  
Jan-12-21 01:19PM  
11:19AM  
Jan-11-21 04:29PM  
11:51AM  
08:11AM  
08:11AM  
06:30AM  
Jan-04-21 06:09AM  
Dec-24-20 07:34AM  
Dec-23-20 10:32AM  
Dec-21-20 05:15PM  
Dec-15-20 11:00AM  
Dec-13-20 11:44AM  
Dec-12-20 03:39PM  
07:20AM  
Dec-10-20 01:45PM  
Dec-08-20 04:45PM  
Dec-07-20 04:30PM  
12:40PM  
Dec-05-20 03:00PM  
12:30PM  
Dec-04-20 11:31AM  
08:00AM  
08:00AM  
Nov-30-20 09:57PM  
Nov-28-20 11:30PM  
Nov-24-20 08:00AM  
Nov-23-20 11:30PM  
Nov-21-20 11:12PM  
Nov-18-20 10:00PM  
Nov-16-20 09:26PM  
Nov-14-20 06:00PM  
Nov-11-20 10:04AM  
Nov-10-20 09:29PM  
08:00AM  
Nov-09-20 11:00AM  
Nov-07-20 08:08AM  
Nov-06-20 06:23AM  
Nov-05-20 04:16PM  
02:27PM  
12:07PM  
11:23AM  
10:11AM  
09:10AM  
07:54AM  
07:30AM  
Nov-04-20 06:35PM  
04:17PM  
04:05PM  
03:16PM  
Nov-03-20 09:08AM  
Oct-22-20 12:33PM  
Oct-20-20 11:55AM  
Oct-11-20 08:50AM  
Oct-04-20 06:27AM  
Oct-02-20 05:00AM  
Sep-28-20 08:00AM  
Sep-23-20 05:00AM  
Sep-22-20 04:22PM  
01:20PM  
06:59AM  
Sep-09-20 09:21PM  
06:09AM  
Sep-04-20 11:31AM  
Sep-02-20 08:00AM  
Aug-29-20 06:30AM  
Aug-17-20 07:00AM  
Aug-12-20 07:22AM  
Aug-11-20 07:01AM  
Aug-06-20 11:42AM  
Aug-05-20 08:25PM  
04:10PM  
08:41AM  
Jul-31-20 08:00AM  
Jul-30-20 12:33PM  
Jul-29-20 04:16PM  
Jul-25-20 11:52AM  
Jul-13-20 01:41PM  
Jul-07-20 12:08PM  
Jul-01-20 08:31AM  
Jun-23-20 08:39AM  
Jun-22-20 04:35PM  
Jun-18-20 02:28AM  
Jun-16-20 06:30AM  
Jun-12-20 01:49PM  
05:30AM  
05:30AM  
Jun-11-20 06:55AM  
Jun-10-20 11:30AM  
Jun-08-20 01:25AM  
Jun-05-20 05:35AM  
Jun-04-20 04:01PM  
Jun-03-20 04:05PM  
May-28-20 08:00AM  
May-27-20 10:35AM  
May-25-20 12:00PM  
May-22-20 11:10AM  
May-19-20 06:53PM  
07:19AM  
bluebird bio, Inc., a biotechnology company, engages in researching, developing, and commercializing of transformative gene therapies for severe genetic diseases and cancer. Its gene therapy programs include LentiGlobin for the treatment of -thalassemia and sickle cell disease; and Lenti-D for the treatment of cerebral adrenoleukodystrophy. The company's product candidates in oncology include bb2121 and bb21217, which are chimeric antigen receptor T (CAR T) cell product candidates for the treatment of multiple myeloma. It has a strategic collaboration with Bristol-Myers Squibb to discover, develop, and commercialize disease-altering gene therapies in oncology; and Regeneron Pharmaceuticals, Inc. to discover, develop, and commercialize various immune cell therapies for cancer. The company also has collaborations with Medigene AG to discover T cell receptor (TCR) product candidates in the field of cancer; Gritstone Oncology, Inc. to discover TCR product candidates in the field of cancer; TC BioPharm Limited to research and develop gamma delta CAR T cells directed at hematologic and solid tumor targets; Forty Seven, Inc. to pursue clinical proof-of-concept for an antibody-based conditioning regimen; and Novo Nordisk A/S to develop in vivo genome editing treatments for genetic diseases, as well as clinical trial collaboration with Magenta Therapeutics. The company was formerly known as Genetix Pharmaceuticals, Inc., and changed its name to bluebird bio, Inc. in September 2010. bluebird bio, Inc. was founded in 1992 and is headquartered in Cambridge, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
FINGER ALISON CECILYChief Commercial OfficerJan 06Sale45.051,81481,72725,103Jan 08 05:57 PM
Baird William D IIIChief Financial OfficerJan 06Sale45.0594942,75622,797Jan 08 05:57 PM
Gregory Philip DChief Scientific OfficerJan 06Sale45.052,754124,07733,007Jan 08 05:56 PM
Davidson DavidChief Medical OfficerJan 06Sale45.053,167142,68436,361Jan 08 05:57 PM
Cole JasonChief Operating andJan 06Sale45.052,358106,23632,823Jan 08 05:56 PM
Smith-Farrell JoanneCOO, OncologyJan 06Sale45.051,28757,98420,609Jan 08 05:56 PM
Leschly NickPresident and CEOJan 06Sale45.0510,095454,81487,263Jan 08 06:18 PM
Leschly NickPresident and CEOJan 05Sale44.9533314,96997,358Jan 08 06:18 PM
Smith-Farrell JoanneCOO, OncologyJan 05Sale44.95421,88821,896Jan 08 05:56 PM
Cole JasonChief Operating andJan 05Sale44.95431,93335,181Jan 08 05:56 PM
Davidson DavidChief Medical OfficerJan 05Sale44.95482,15839,528Jan 08 05:57 PM
Gregory Philip DChief Scientific OfficerJan 05Sale44.95452,02335,761Jan 08 05:56 PM
FINGER ALISON CECILYChief Commercial OfficerJan 05Sale44.95401,79826,917Jan 08 05:57 PM
Burnett KatyPrincipal Accounting OfficerDec 03Sale46.091235,6691,460Dec 04 04:49 PM
Leschly NickPresident and CEODec 02Sale46.2044420,51297,691Dec 04 04:48 PM
Davidson DavidChief Medical OfficerDec 02Sale46.20642,95739,576Dec 04 04:48 PM
Gregory Philip DChief Scientific OfficerDec 02Sale46.20592,72635,806Dec 04 04:48 PM
Cole JasonChief Operating andDec 02Sale46.20381,75635,224Dec 04 04:48 PM
Smith-Farrell JoanneCOO, OncologyDec 02Sale46.20381,75621,938Dec 04 04:48 PM
FINGER ALISON CECILYChief Commercial OfficerDec 02Sale46.20361,66326,957Dec 04 04:48 PM
Leschly NickPresident and CEONov 02Sale52.9444423,50698,135Nov 04 04:04 PM
Davidson DavidChief Medical OfficerNov 02Sale52.94633,33539,640Nov 04 04:05 PM
Gregory Philip DChief Scientific OfficerNov 02Sale52.93593,12335,865Nov 04 04:05 PM
Cole JasonChief Operating andNov 02Sale52.97371,96035,262Nov 04 04:05 PM
Smith-Farrell JoanneCOO, OncologyNov 02Sale52.97371,96021,976Nov 04 04:05 PM
FINGER ALISON CECILYChief Commercial OfficerNov 02Sale52.99351,85526,993Nov 04 04:05 PM
Davidson DavidChief Medical OfficerOct 02Sale52.77643,37739,703Oct 06 04:06 PM
Gregory Philip DChief Scientific OfficerOct 02Sale52.77603,16635,924Oct 06 04:05 PM
Leschly NickPresident and CEOOct 02Sale52.7745023,74498,579Oct 06 04:05 PM
FINGER ALISON CECILYChief Commercial OfficerOct 02Sale52.77361,90027,028Oct 06 04:05 PM
Smith-Farrell JoanneChief Business OfficerOct 02Sale52.77382,00522,013Oct 06 04:06 PM
Cole JasonChief Operating andOct 02Sale52.77382,00535,299Oct 06 04:06 PM
Davidson DavidChief Medical OfficerSep 03Sale58.60412,40339,767Sep 08 04:07 PM
Gregory Philip DChief Scientific OfficerSep 03Sale58.60583,39935,984Sep 08 04:08 PM
Cole JasonChief Operating andSep 03Sale58.60362,11035,337Sep 08 04:08 PM
Smith-Farrell JoanneChief Business OfficerSep 03Sale58.60362,11022,051Sep 08 04:08 PM
FINGER ALISON CECILYChief Commercial OfficerSep 03Sale58.60352,05127,063Sep 08 04:08 PM
Leschly NickPresident and CEOSep 03Sale58.6043125,25799,029Sep 08 04:07 PM
Smith-Farrell JoanneChief Business OfficerAug 25Sale58.9522513,26422,087Aug 27 05:11 PM
WENTWORTH KORY JAMESPrincipal Accounting OfficerAug 03Sale61.00825,0029,512Aug 05 04:06 PM
Smith-Farrell JoanneChief Business OfficerAug 03Sale60.48372,23822,312Aug 05 04:05 PM
Cole JasonChief Operating andAug 03Sale60.48372,23835,373Aug 05 04:05 PM
Leschly NickPresident and CEOAug 03Sale60.4944426,85699,460Aug 05 04:05 PM
Davidson DavidChief Medical OfficerAug 03Sale60.75422,55239,808Aug 05 04:06 PM
Gregory Philip DChief Scientific OfficerAug 03Sale60.49593,56936,042Aug 05 04:05 PM
FINGER ALISON CECILYChief Commercial OfficerAug 03Sale60.49352,11727,098Aug 05 04:05 PM
WENTWORTH KORY JAMESPrincipal Accounting OfficerJul 20Sale66.3859639,5629,594Jul 22 05:22 PM
Smith-Farrell JoanneChief Business OfficerJul 02Sale61.57382,34022,349Jul 07 05:17 PM
Leschly NickPresident and CEOJul 02Sale61.5744327,27799,904Jul 07 05:19 PM
Cole JasonChief Operating andJul 02Sale61.57382,34035,410Jul 07 05:18 PM
Davidson DavidChief Medical OfficerJul 02Sale61.57422,58639,850Jul 07 05:22 PM
Gregory Philip DChief Scientific OfficerJul 02Sale61.57593,63336,101Jul 07 05:15 PM
FINGER ALISON CECILYChief Commercial OfficerJul 02Sale61.57362,21727,133Jul 07 05:16 PM
Smith-Farrell JoanneChief Business OfficerJun 04Sale65.2317011,08922,387Jun 08 04:24 PM
WENTWORTH KORY JAMESPrincipal Accounting OfficerJun 04Sale65.2315410,04510,190Jun 08 04:24 PM
Davidson DavidChief Medical OfficerJun 02Sale64.03422,68939,892Jun 04 05:44 PM
Cole JasonChief Operating andJun 02Sale64.03382,43335,448Jun 04 05:44 PM
Smith-Farrell JoanneChief Business OfficerJun 02Sale64.03372,36922,557Jun 04 05:44 PM
Gregory Philip DChief Scientific OfficerJun 02Sale64.03593,77836,160Jun 04 05:43 PM
FINGER ALISON CECILYChief Commercial OfficerJun 02Sale64.04352,24127,169Jun 04 05:44 PM
Leschly NickPresident and CEOJun 02Sale64.0444428,433100,347Jun 04 05:44 PM
Smith-Farrell JoanneChief Business OfficerMay 04Sale50.1723211,63922,594May 05 04:05 PM
Smith-Farrell JoanneChief Business OfficerApr 06Sale43.7358325,49521,393Apr 08 04:12 PM
Baird William D IIIChief Financial OfficerFeb 13Sale90.601,254113,61213,746Feb 18 07:14 PM